Antimicrobial resistance (AMR) causes 1.3 million deaths and contributes to 5 million deaths every year. By 2030, AMR could force 24 million people into extreme poverty. The drivers of AMR are multifaceted. New and affordable diagnostic testing, disease-prediction tools, vaccines, and non-antimicrobial alternatives do not exist for several infectious diseases. Research is needed to help identify the best possible interventions, solutions and approaches in a multi-disciplinary and multi-sectoral manner. Financial and political commitment, as well as scientific interest, through engagement of governments, private sector, and civil society are crucial.
The high-level Global Leaders Group (GLG) – European Society of Clinical Microbiology and Infectious Diseases (ESCMID) joint event will provide a forum in which policymakers and distinguished scientists can engage on key AMR issues and forge partnerships between science and policy. Heads of government and ministers across the One Health spectrum as well as renowned scientists will participate. This event is intended to strengthen the links between research, policy and practice to generate sustainable solutions and a broader research agenda to address the pressing needs of AMR across all sectors.
The event can be attended in-person and will be livestreamed over ESCMID YouTube, ESCMID Facebook, GLG Twitter and GLG LinkedIn.